Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 15/20 | 0.94 |
| ▸ | AGXT | P21549 | 12/20 | 0.90 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7948 | 0.97 | — | — | |
| SCHEMBL20469087 | 0.97 | IDO1 (1.00) | IDO1AGXTTSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL128937 | 0.94 | AGXT (1.00) | IDO1AGXTTSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL27822689 | 0.94 | AGXT (1.00) | IDO1AGXTTSHRCYP3A4 | |
| SCHEMBL8863651 | 0.94 | IDO1 (0.94) | IDO1AGXTTSHRCYP3A4 | |
| SCHEMBL8021019 | 0.94 | IDO1 (0.94) | IDO1AGXTTSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL26910207 | 0.94 | AGXT (1.00) | IDO1AGXTTSHRCYP3A4 | |
| Water SCHEMBL29938838 | 0.92 | IDO1 (0.90) | IDO1AGXTTSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL4870367 | 0.92 | IDO1 (0.90) | IDO1AGXTTSHRCYP3A4 | |
| Hypochlorous Acid SCHEMBL4229241 | 0.90 | IDO1 (0.85) | IDO1AGXTTSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111646991-B | Preparation method of avibactam sodium intermediate | 浙江海翔药业股份有限公司 | 2021-08-24 | — | — | CN | claimed |
| CN-109912499-B | Abamebactam intermediate and preparation method thereof | 江苏奥赛康药业有限公司 | 2021-04-27 | — | — | CN | claimed |
| CN-108264480-B | Preparation method of avibactam sodium intermediate | 上海星泰医药科技有限公司 | 2020-12-11 | — | — | CN | claimed |
| CN-111646991-A | Preparation method of avibactam sodium intermediate | 浙江海翔药业股份有限公司 | 2020-09-11 | — | — | CN | claimed |
| CN-111646991-B | Preparation method of avibactam sodium intermediate | 浙江海翔药业股份有限公司 | 2021-08-24 | — | — | CN | disclosed |
| CN-109912499-B | Abamebactam intermediate and preparation method thereof | 江苏奥赛康药业有限公司 | 2021-04-27 | — | — | CN | disclosed |
| CN-108264480-B | Preparation method of avibactam sodium intermediate | 上海星泰医药科技有限公司 | 2020-12-11 | — | — | CN | disclosed |
| CN-111646991-A | Preparation method of avibactam sodium intermediate | 浙江海翔药业股份有限公司 | 2020-09-11 | — | — | CN | disclosed |
| US-5480873-A | ARTHRITIS | LILLY INDUSTRIES LIMITED (GB) | 1996-01-02 | — | — | US | disclosed |
| EP-0570091-A1 | Anthraquinone derivatives, process for their preparation and their use as medicaments | LILLY INDUSTRIES LIMITED (GB) | 1993-11-18 | — | — | EP | disclosed |